Antimicrobial Resistance News and Research

RSS

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs' benefits among the wider population, a new study suggests.

25 Aug 2020

Drug resistance may be reversed using hydrogen sulphide

Antibiotic resistance in some kinds of bacteria may be reversed using hydrogen sulphide (H2S), according to a new study.

24 Aug 2020

Honey a better cough remedy than over-the-counter-medicines

Cough has many remedies, but one of the most popular ones is honey, which has been used for centuries. Now, new research claims honey may be a better treatment for cough and colds than over-the-counter medicines.

20 Aug 2020

Poor hygiene and antibiotic use can contribute to colonization of antimicrobial-resistant bacteria

Scientists have found clear indicators for how the interaction of poor hygiene and antibiotic use contribute to the colonization of antimicrobial-resistant (AMR) bacteria in humans, a problem that contributes to hundreds of thousands of deaths annually.

15 Aug 2020

SMART researchers discover new way to reverse antibiotic resistance in some bacteria

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have discovered a new way to reverse antibiotic resistance in some bacteria using hydrogen sulfide.

12 Aug 2020

Using medieval medicine to find new treatments for modern-day infections

News-Medical spoke to researchers from the University of Warwick about their research investigating natural antimicrobials and their potential as antibiotics.

11 Aug 2020

Finland joins international organization dedicated to COVID-19 vaccines

The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country's accession to IVI.

11 Aug 2020

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Yellow fever, an acute viral hemorrhagic disease transmitted by infected mosquitoes, infects about 200,000 people and causes an estimated 30,000 deaths each year.

5 Aug 2020

Compounds demonstrate promising activity against tuberculosis

Compounds tested for their potential as antibiotics have demonstrated promising activity against one of the deadliest infectious diseases - tuberculosis (TB).

30 Jul 2020

New edition of trilateral study on access to medical technologies and innovation launched

On 29 July, the Directors-General of the World Health Organization, the World Intellectual Property Organization and the WTO presented a new edition of the Trilateral Study on Access to Medical Technologies and Innovation.

29 Jul 2020

Researchers analyze global trends of antibiotic consumption in each WHO AWaRe category

Antibiotic consumption per capita increased nearly 40 percent worldwide between 2000 and 2015, primarily driven by increases in low- and middle-income countries (LMICs) where lack of access to antibiotics exists alongside overuse.

28 Jul 2020

Researchers identify practical way to induce strong and broad immunity to dengue virus

Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have found a practical way to induce a strong and broad immunity to the dengue virus based on proof-of-concept studies in mice.

28 Jul 2020

Patients with frailty, older age and UTIs have higher risk of developing sepsis

Patients with frailty, older age and urinary tract infections are at greatest risk of developing sepsis following infection consultations in primary care, research has found.

24 Jul 2020

New technology could speed up drug discovery to fight tuberculosis

A new technology that combines high throughput imaging and machine learning could speed discovery of drugs to fight tuberculosis, which for generations has killed more people worldwide than any other disease caused by a single agent - 4,000 people every day.

23 Jul 2020

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, and Heriot-Watt University, a specialist, pioneering Scottish University, today announced they have been awarded a Knowledge Transfer Partnership (KTP) grant from Innovate UK, the UK’s innovation agency.

From Fluidic Sciences and Sphere Bio 20 Jul 2020

Antimicrobial Resistance News and Research

Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits

Drug resistance may be reversed using hydrogen sulphide

Honey a better cough remedy than over-the-counter-medicines

Poor hygiene and antibiotic use can contribute to colonization of antimicrobial-resistant bacteria

SMART researchers discover new way to reverse antibiotic resistance in some bacteria

Using medieval medicine to find new treatments for modern-day infections

Finland joins international organization dedicated to COVID-19 vaccines

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Compounds demonstrate promising activity against tuberculosis

New edition of trilateral study on access to medical technologies and innovation launched

Researchers analyze global trends of antibiotic consumption in each WHO AWaRe category

Researchers identify practical way to induce strong and broad immunity to dengue virus

Patients with frailty, older age and UTIs have higher risk of developing sepsis

New technology could speed up drug discovery to fight tuberculosis

Sphere Fluidics and Heriot-Watt University collaborate to develop next generation droplet generator instrumentation

Bird poop may harbor abundant antibiotic resistance genes

7-day levofloxacin/dexamethasone eye drops as effective as standard treatment after cataract surgery

Easy-to-use software developed to identify drug-resistant genes in bacteria

New technique could help fight the global threat of antibiotic resistance

Antibiotic resistance genes tend to persist in E. coli through 'genetic capitalism'

Industry Focus: Infectious Diseases eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News